Can infections cause neutropenia, and how should a patient presenting with a low absolute neutrophil count during an acute infection be evaluated and treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Infections Cause Neutropenia?

Yes, infections can cause neutropenia—viral infections are well-recognized causes of transient neutropenia, and patients presenting with low absolute neutrophil counts during acute infection require immediate evaluation for both the infection and the underlying cause of neutropenia. 1, 2

Mechanisms by Which Infections Cause Neutropenia

Viral infections are the primary infectious cause of transient neutropenia, with specific pathogens including CMV, EBV, HIV, parvovirus, and hepatitis B/C causing temporary drops in neutrophil counts 1. The mechanism involves either direct viral suppression of bone marrow production, accelerated neutrophil consumption at sites of infection, or redistribution of neutrophils from the circulating pool 3, 4.

Bacterial infections typically cause neutrophilia (elevated neutrophil counts) rather than neutropenia, though severe overwhelming bacterial sepsis can paradoxically deplete neutrophil reserves and cause neutropenia 5. This occurs when neutrophil consumption exceeds production capacity during severe septicemia 6.

Immediate Evaluation of Neutropenic Patients with Acute Infection

Severity Assessment

Determine the absolute neutrophil count (ANC) immediately, as this dictates management urgency 1:

  • Mild to moderate neutropenia (ANC >500 cells/µL): Lower infection risk, can be managed with observation and monitoring 1
  • Severe neutropenia (ANC <500 cells/µL): High infection risk requiring immediate intervention 1, 7
  • Profound neutropenia (ANC <200 cells/µL): Extremely high risk with significantly increased morbidity and mortality 8, 3

Critical Diagnostic Steps

Perform a comprehensive medication review first, as drugs are a common reversible cause of neutropenia, including chemotherapy agents, immunosuppressants, antibiotics (particularly beta-lactams and sulfonamides), and anticonvulsants 1. This is the highest-yield initial step.

Obtain viral serologies for CMV, EBV, HIV, parvovirus B19, and hepatitis B/C to identify treatable viral causes of transient neutropenia 1. These infections are reversible causes that resolve with treatment or spontaneously.

Check nutritional markers including vitamin B12, folate, and copper levels, as deficiencies can cause neutropenia that mimics infection-related causes 1.

Examine the peripheral blood smear to distinguish true neutropenia from pseudo-neutropenia and identify morphologic abnormalities suggesting specific etiologies 6.

Treatment Algorithm Based on Clinical Presentation

Febrile Neutropenia (Fever + ANC <500 cells/µL)

Initiate empiric broad-spectrum antibiotics immediately covering gram-negative bacteria (especially Pseudomonas aeruginosa) and gram-positive organisms, as infections can become rapidly fatal in this population 8, 2. The Infectious Diseases Society of America guidelines should direct specific antibiotic selection 8.

Add antimicrobial prophylaxis for severe neutropenia including fluoroquinolones with streptococcal coverage (or fluoroquinolone plus penicillin), acyclovir (or congeners), and fluconazole 8, 1. Continue until ANC recovers to ≥500 cells/µL 8.

Non-Febrile Neutropenia with Infection

For patients with severe neutropenia (ANC <500 cells/µL) without fever, implement prophylactic antimicrobials including antibacterial, antiviral, and antifungal agents to prevent infections 1. This is critical even in asymptomatic patients.

Consider G-CSF (filgrastim) for severe, prolonged neutropenia, particularly in congenital or idiopathic cases, at doses of 5-10 mcg/kg/day subcutaneously 1, 9, 7. Monitor weekly complete blood counts during treatment 1.

Mild Neutropenia (ANC >500 cells/µL)

Manage with observation and regular monitoring with repeat complete blood counts every 3 months initially 1. Educate patients on signs of infection requiring urgent evaluation including fever, chills, and sore throat 1.

Critical Pitfalls to Avoid

Do not confuse relative lymphocytosis with absolute lymphocytosis—a low ANC with high lymphocyte percentage but normal absolute lymphocyte count indicates neutropenia causing a relative shift, not a lymphoproliferative disorder like CLL 1. This is a common source of unnecessary workup.

Recognize benign ethnic neutropenia in individuals of African descent, which does not increase infection risk and should not trigger extensive evaluation 1. These patients have chronically lower baseline ANCs (often 1000-1500 cells/µL) without clinical consequences.

Do not empirically administer gut prophylaxis with anaerobic coverage unless clinically indicated (abdominal wound, C. difficile), as altering anaerobic gut flora may worsen outcomes in neutropenic patients 8.

In immunocompromised patients, fever may be the only sign of infection—do not wait for localizing symptoms before initiating broad-spectrum antibiotics 8. Immunosuppressed patients demonstrate minimal other evidence of infection even with serious bacterial or fungal disease.

Special Populations

AIDS patients have neutropenia in 20-25% of cases due to HIV itself, medications, or opportunistic infections, and require empiric broad-spectrum antibiotics including staphylococcal prophylaxis when presenting with fever 8.

Oncology patients receiving chemotherapy develop neutropenia lasting 4-58 days, with over 60% of catheter-related sepsis occurring during neutropenic periods (ANC <500/mm³) 8. These patients require aggressive antimicrobial prophylaxis and may benefit from catheter salvage strategies rather than removal 8.

References

Guideline

Management of Neutropenia with Relative Lymphocytosis and Basophilia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Neutropenia Associated with Immunizations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Why is my patient neutropenic?

Hematology/oncology clinics of North America, 2012

Guideline

Neutrophilic Leukocytosis Causes and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Neutropenia: causes and consequences.

Seminars in hematology, 2002

Research

How I diagnose and treat neutropenia.

Current opinion in hematology, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.